New York State Common Retirement Fund Aligos Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.04 - $2.14 $13,912 - $28,626	-13,377 Reduced 98.75%	169 $0
Q4 2021 Feb 02, 2022	SELL	$11.48 - $17.69 $31,615 - $48,718	-2,754 Reduced 16.9%	13,546 $161,000
Q3 2021 Nov 02, 2021	BUY	$14.57 - $17.72 $1,486 - $1,807	102 Added 0.63%	16,300 $253,000
Q2 2021 Aug 02, 2021	BUY	$20.3 - $33.6 $131,909 - $218,332	6,498 Added 66.99%	16,198 $330,000
Q1 2021 May 11, 2021	BUY	$19.1 - $34.94 $76,400 - $139,760	4,000 Added 70.18%	9,700 $221,000
Q4 2020 Feb 08, 2021	BUY	$13.2 - $32.74 $75,240 - $186,618	5,700 New	5,700 $158,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.